Capsugel opens dosage form solutions business unit
The DFS unit will leverage the company’s proprietary technology platforms including lipid-based formulations and targeted release capsule formulation, R&D capabilities and commercial manufacturing infrastructure to develop and manufacture
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.